A Novel Diamino-Pyridine Derivative Prevents Excessive Leukocyte Infiltration in Aggravation of Acute Necrotizing Pancreatitis
A Novel Diamino-Pyridine Derivative Prevents Excessive Leukocyte Infiltration in Aggravation of Acute Necrotizing Pancreatitis
复制标题
一种新型二氨基吡啶衍生物可防止白细胞过度浸润导致急性坏死性胰腺炎恶化
作者:
J. Yamauchi;M. Sunamura;K. Shibuya;K. Takeda;M. Kobari;S. Matsuno
Leukocyte infiltration in the pancreas is involved in the aggravation of acute pancreatitis from edematous phase into necrotic change, and mild disease into severe disease; however, the mechanism responsible for leukocyte accumulation is not fully understood. This study was designed to clarify the mechanism underlying leukocyte accumulation into the pancreas and to elucidate the therapeutic efficacy of a novel diamino-pyridine derivative, IS-741 on leukocyte-endothelial cell interaction using rat necrotizing pancreatitis model. The number of adherent leukocytes to pancreatic collecting venules assessed by in vivo fluorescence microscopy increased significantly in necrotizing pancreatitis animals in a time-dependent manner. The expression of CD11b on circulating neutrophils determined by flow cytometric analysis was enhanced to approximately 500% after 2 h. IS-741 attenuated the leukocyte adherence significantly, accompanied by a lower up-regulation of CD11b. These findings were further supported by the histological examination that the accumulation of leukocytes in the pancreas was remarkably inhibited by IS-741. These results suggest that the leukocyte accumulation in the early phase of acute necrotizing pancreatitis may be mediated by leukocyte-endothelial cell interaction via leukocyte integrin CD11b/18. IS-741 attenuated the leukocyte endothelial cell interaction as a consequence of its inhibitory effect on CD11b upregulation.
影响因子:
20.3
作者:
T. Carlos;J. Harlan
通讯作者:
T. Carlos;J. Harlan
DOI:
10.1152/ajpgi.1997.272.1.g23
发表时间:
1997
期刊:
The American journal of physiology
影响因子:
--
作者:
Yamanaka,K;Saluja,AK;Brown,GE;Yamaguchi,Y;Hofbauer,B;Steer,ML
通讯作者:
Steer,ML